A Beautiful iOS 7 Concept and Wish Lists...

On June 11 at around 1 am (PhST), the keynote at Apple's 2013 Worldwide Developer's Conference will start and we'll find out when iOS 7 will be coming out.  iOS is among the most anticipated Apple products at this time since this is were we will finally see the results of Apple's 230 days of silence (since they released the iPad Mini on October 23, 2012) and their counter to their competitor's efforts of which there are a lot!  (To see what's been happening to the gadget world since the iPad Mini release check this excellent article...)

They may announce iOS 7 tomorrow, or they many not.  but this is a small video that not only shows you how it MAY look like, but also summarizes the most common wish list items people have been screaming for in a future iOS release.


Aside from the announced "flatter" appearance by Jony Ive, which are cosmetic after all, they show:

• A sleeker and more functional lock screen.
• Customizable widgets so that the content of your choice can instantly bee seen on the home screen.
• A more intuitive calendar app.
• A cleaner camera gui.
• A simpler and more useful Siri screen.

Every veteran iOS user has their own wish list.  There are also a slew of articles out there about their own wish lists.  Let me give you mine:

Early Detection of Prostate Cancer: AUA GUIDELINE

The PSA era started at the end of 1980's, even though it had been discovered as far back as the 70's. Although it is common knowledge that an elevated PSA is an indicator for prostate cancer, exactly how to use it in determining the next step in a patient's management has always been controversial.

In fact, in May 2012 the U.S. Preventive Services Task Force released a recommendation, "against PSA-based screening for prostate cancer."

"Prostate cancer is a serious health problem that affects thousands of men and their families. But before getting a PSA test, all men deserve to know what the science tells us about PSA screening: there is a very small potential benefit and significant potential harms. We encourage clinicians to consider this evidence and not screen their patients with a PSA test unless the individual being screened understands what is known about PSA screening and makes the personal decision that even a small possibility of benefit outweighs the known risk of harms."

The also conclude that, "many men are harmed as a result of prostate cancer screening and few, if any, benefit."  They rated this as a Grade D recommendation, which is indicates that, 

"The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits." And that they, "Discourage the use of this service." Such a sweeping recommendation by a prominent agency prompted the American Urological Association to respond within a month. Dr. John M. Lynch said,  © Fox Broadcasting Corporation "I think we would all agree that the appropriate use of PSA and DRE, combined with informed consent, especially in at-risk populations, does indeed reduce deaths from prostate cancer. It is a disservice to men to deny them the opportunity for potential treatment and cure, when necessary, for a disease that affects one in six over the course of their lifetime."  These reflect my own personal opinions on Prostate Cancer screening. These are think are the keywords for practical consideration.  PSA should be combined with DRE... a patient should be informed about the issues about screening... AND it is absolutely essential for patients who are at risk! This seems to have stimulated the AUA to produce a concrete set of guidelines for the Early Detection of Prostate Cancer which is now sort of an update to their previous 2009 Prostate-Specific Antigen Best Practice Statement.